Compare Amylx Pharmaceuticals Inc (AMLX) vs Tractor Supply Co (TSCO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Tractor Supply Co — how do they compare? Amylx Pharmaceuticals Inc trades at $17.77 (market cap $1.98B), while Tractor Supply Co trades at $30.5 (market cap $15.96B). The key difference: Tractor Supply Co is far larger — about 8.1× Amylx Pharmaceuticals Inc's market cap, and Tractor Supply Co pays a 3.15% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | TSCO | |
|---|---|---|
Market Cap | $1.98B | $15.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $18.70 | $62.65 |
52-Week Low | $7.64 | $29.14 |
Enterprise Value | $1.70B | $22.14B |
Dividend Yield | — | 3.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMLX trades at $17.77, down 3.32% today, with a bullish technical signal from moving averages and strong analyst support. The company is in a pivotal phase with key Phase 3 data for avexitide expected in Q3 2026, targeting a potential 2027 launch. Financially, it shows significant losses with negative ROE and ROA, but cash flow from financing activities provides runway. Recent news highlights clinical progress and conference presentations, alongside ongoing class action settlement discussions.
The outlook hinges on successful clinical trial outcomes, particularly avexitide's Phase 3 readout, which could drive substantial upside toward the $30.50 consensus price target. However, high execution risk, persistent cash burn, and legal overhangs pose threats to near-term stability. Investor sentiment remains cautiously optimistic given the 90.9% buy rating from analysts, but the stock is speculative until profitability milestones are achieved.
Tractor Supply (TSCO) trades at $30.43, up 1.0% on the day, with a bearish technical signal despite neutral oscillators. The company maintains stable revenue growth to $15.52B in 2025 with consistent $1.1B net income, though profit margins show slight compression. Recent earnings show mixed results with Q2 2026 expectations at $0.85 EPS. Analyst consensus is divided with 48% buy ratings and a $42.15 price target, representing 38% upside potential from current levels.
TSCO presents a compelling valuation case with P/E of 14.99 below industry averages, supported by strong ROE of 45.5% and dividend payments. Key risks include recent earnings misses, competitive retail pressures, and consumer spending sensitivity. The stock's current technical weakness near support at $29 creates potential entry opportunity for value-oriented investors seeking rural retail exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
